Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.59 | -0.88 | 0.11 | -0.84 |
| FCF Yield | -0.64% | 2.88% | 1.56% | -0.34% |
| EV / EBITDA | 95.90 | 79.14 | 52.21 | 81.82 |
| Quality | ||||
| ROIC | 1.30% | 1.50% | 2.18% | 1.04% |
| Gross Margin | 21.39% | 25.45% | 23.16% | 20.96% |
| Cash Conversion Ratio | 0.02 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -1.79% | -2.45% | -4.81% | -4.97% |
| Free Cash Flow Growth | -128.54% | 124.84% | 609.51% | -122.81% |
| Safety | ||||
| Net Debt / EBITDA | -0.98 | -3.37 | -1.22 | 0.22 |
| Interest Coverage | 21.41 | 16.59 | 33.20 | 18.86 |
| Efficiency | ||||
| Inventory Turnover | 1.67 | 1.54 | 1.59 | 1.57 |
| Cash Conversion Cycle | 52.28 | 25.40 | 38.29 | 29.79 |